Quarterly report · Q3
3762.TEDINET S100Q7PI
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥32.3bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥11.5bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥36.5bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥25.1bn | 2021-04-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥9.0bn | 2021-10-01 → 2021-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥2.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥913m | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥2.4bn | 2021-04-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥815m | 2021-10-01 → 2021-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥2.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥893m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥2.4bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥805m | 2021-10-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥514m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥524m | 2021-10-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥1.9bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥614m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥2.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥1.7bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥561m | 2021-10-01 → 2021-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥62.2bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥52.5bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥43.7bn | at 2021-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥40.1bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥32.3bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥22.1bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥20.2bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥17.2bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥16.4bn | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥17.5bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥17.0bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥15.6bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥16.3bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥18.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥13.6bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥5.3bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.9bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥2.8bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥196m | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.3bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥1.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.7bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥39.52 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥12.87 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥59.65 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥39.5 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥13.18 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥39.41 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥12.83 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥59.46 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥39.38 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥13.14 | 2021-10-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 28.2% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 32.4% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 35.7% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥349m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥349m |
| jpcrp040300-q3r_E05463-000Application Servicereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥5.3bn |
| jpcrp040300-q3r_E05463-000Application Servicereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E05463-000Application Servicereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥116m |
| jpcrp040300-q3r_E05463-000Application Servicereportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥166m |
| jpcrp040300-q3r_E05463-000Information Infrastructurereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥21.2bn |
| jpcrp040300-q3r_E05463-000Information Infrastructurereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥21.0bn |
| jpcrp040300-q3r_E05463-000Information Infrastructurereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥230m |
| jpcrp040300-q3r_E05463-000Information Infrastructurereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.0bn |
| jpcrp040300-q3r_E05463-000Medical System Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.1bn |
| jpcrp040300-q3r_E05463-000Medical System Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥6.1bn |
| jpcrp040300-q3r_E05463-000Medical System Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2m |
| jpcrp040300-q3r_E05463-000Medical System Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥32.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥32.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥349m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥260m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥260m |
| jpcrp040300-q3r_E05463-000Application Servicereportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥5.3bn |
| jpcrp040300-q3r_E05463-000Application Servicereportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E05463-000Application Servicereportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥57m |
| jpcrp040300-q3r_E05463-000Application Servicereportable segment | segment profit | 2021-04-01 → 2021-12-31 | −¥50m |
| jpcrp040300-q3r_E05463-000Information Infrastructurereportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥17.8bn |
| jpcrp040300-q3r_E05463-000Information Infrastructurereportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥17.6bn |
| jpcrp040300-q3r_E05463-000Information Infrastructurereportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥182m |
| jpcrp040300-q3r_E05463-000Information Infrastructurereportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E05463-000Medical System Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E05463-000Medical System Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E05463-000Medical System Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥21m |
| jpcrp040300-q3r_E05463-000Medical System Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥390m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥25.4bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥25.1bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥260m |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 765
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenue from external customers IFRS | CurrentYTDDuration | 32285456000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember | 230043000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember | 116284000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember | 2336000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReportableSegmentsMember | 348664000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -348664000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration | - | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember | 21247494000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember | 5268115000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember | 6118511000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReportableSegmentsMember | 32634121000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -348664000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 32285456000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember | 1955696000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember | -165892000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember | 1038582000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReportableSegmentsMember | 2828386000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 2828386000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 30750000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 42864000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | -8336000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 2807935000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-02-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第39期第3四半期(自 2022年10月1日 至 2022年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)テクマトリックス株式会社 | |
| Company name in english cover page | FilingDateInstant | TECHMATRIX CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 由 利 孝 | |
| Address of registered headquarter cover page | FilingDateInstant | Text · Plus | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03(4405)7800(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)コーポレート本部 経営企画部長 山 﨑 基 貴 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区港南一丁目2番70号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03(4405)7800(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)コーポレート本部 経営企画部長 山 﨑 基 貴 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05463 | |
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 37620 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)テクマトリックス株式会社 | |
| Filer name in english | FilingDateInstant | TECHMATRIX CORPORATION | |
| Fund name in japanese | FilingDateInstant | - | |
| Fund name in english | FilingDateInstant | - | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |